Abstract
Hereditary syndromes account for 5% to 10% of cases of colorectal cancer. In clinical practice, patients with these syndromes need to be identified to ensure that they and their families receive genetic counseling and testing and appropriate risk-reducing treatment. Genetic testing can offer a precise diagnosis. It allows for risk stratification and focused management and surveillance.
MeSH terms
-
Adenoma / diagnosis
-
Adenomatous Polyposis Coli* / diagnosis
-
Adenomatous Polyposis Coli* / genetics
-
Adenomatous Polyposis Coli* / prevention & control
-
Adenomatous Polyposis Coli* / therapy
-
Age of Onset
-
Colorectal Neoplasms, Hereditary Nonpolyposis* / diagnosis
-
Colorectal Neoplasms, Hereditary Nonpolyposis* / genetics
-
Colorectal Neoplasms, Hereditary Nonpolyposis* / prevention & control
-
Colorectal Neoplasms, Hereditary Nonpolyposis* / therapy
-
Family Health
-
Genetic Counseling / methods
-
Genetic Counseling / standards*
-
Genetic Predisposition to Disease*
-
Genetic Testing / standards*
-
Humans